Study finds infection rates on the rise in the USA, particularly among people with diabetes

October 02, 2018

Infection-related hospitalisations in the USA are on the rise, particularly among people with diabetes, suggesting that more must be done to protect people with diabetes from preventable complications, according to new research being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, Germany (1-5 October).

The study, which examined infection-related hospitalisation rates in US adults (aged 18 and older), for more than 15 years, found increasing infection rates for urinary tract infections, sepsis, and skin infections among people with diabetes.

Although cardiovascular disease (CVD) and mortality complications of diabetes are on the decline in the USA, little was known about the trends in non-CVD complications, such as infections, before this latest research.

To investigate trends in hospital admissions for infections, Dr Jessica Harding from the Centers for Disease Control and Prevention (CDC) in Atlanta, USA and colleagues analysed data from the 2000-2015 National Inpatient Sample, a database that captures approximately 20% of all in-patient hospitalisations from 46 states representing more than 96% of the US population.

The study found that people with diabetes are around two to seven times more likely to be hospitalised with an infection than the general population, depending on infection type.

Rates of infection-related hospitalisations increased 52% in people with diabetes between 2010 and 2015 (from 15.7 to 23.8 per 1,000 people) compared to 17% between 2012 and 2015 (from 6.7 to 7.8) in people without diabetes. Respiratory tract infections and skin and connective tissue infections remained the most common infection types among hospitalisations for people with and without diabetes [1].

Increases in overall infection rates were driven largely by increases in urinary tract infections and hospital-acquired infections (specifically sepsis) in people with and without diabetes, as well as skin and connective tissue infections among young people with diabetes.

"Our findings show that people with diabetes have especially high levels of infection-related hospitalisations", says Jessica Harding, PhD, with CDC's Division of Diabetes Translation. "By identifying and addressing the factors that put people at risk of infection-related hospitalisations, we can work to improve the overall care delivered in our healthcare system. More research is critical to determine the exact causes behind these increases."


Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to